PhaseV has formed a strategic collaboration with Alimentiv to support the design and execution of adaptive clinical trials ...

Gastrointestinal-focused CRO Alimentiv is upgrading its clinical trials with software firm PhaseV’s adaptive trial technology ...

PhaseV, a pioneer in software and machine learning (ML) for advanced clinical development optimization, announced today the launch of its new webinar series exploring the latest innovations in ...

PhaseV's Adaptive Clinical Trials Platform Will Support the Gastrointestinal CRO in Addressing a Wide Range of GI-Related Conditions The collaboration has the potential to accelerate the ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...

Newronika announced today that it closed a €13.6 million ($14.1 million) Series B round to support its deep brain stimulation ...

For people living with Type 1 Diabetes, keeping blood sugar levels in check is a constant challenge. A new clinical trial at ...

Hip fractures in older adults can lead to serious complications, disability and even death. Traditionally, orthopaedic ...

A new $10.8 million multicenter clinical trial co-led by Gerard Slobogean, MD, MPH, an Associate Professor of Orthopaedics ...

PhaseV has formed a strategic collaboration with Alimentiv to support the design and execution of adaptive clinical trials targeting gastrointestinal (GI) conditions. This collaboration ...